Jump to content
This site uses cookies. Continued use is acceptance of our Terms of Use and Privacy Policy. More Info... ×
  • Welcome to Celiac.com!

    You have found your celiac tribe! Join us and ask questions in our forum, share your story, and connect with others.




  • Celiac.com Sponsor (A1):



    Celiac.com Sponsor (A1-M):


  • Get Celiac.com Updates:
    Support Our Content
    eNewsletter
    Donate
  • Scott Adams
    Scott Adams

    Ukko Raises $40M for AI-enabled Gluten-Free Allergy and Food Solutions

    Reviewed and edited by a celiac disease expert.

    Ukko will use AI-design to create non-allergenic gluten protein and gluten-neutralized ingredients that can be used to in baked goods for celiacs and people with gluten sensitivity.

    Ukko Raises $40M for AI-enabled Gluten-Free Allergy and Food Solutions - Image: Ukko
    Caption: Image: Ukko

    Celiac.com 07/29/2021 - Ukko, a company focused on developing artificial-intelligence designed products and solutions to food allergies, just announced a successful $40 million funding round. 

    Their first effort will be to develop non-allergenic gluten protein and gluten-neutralized ingredients that can be used to in baked goods for celiacs and people with gluten sensitivity.

    Celiac.com Sponsor (A12):
    At the same time, they are also working on a safe peanut allergy treatment that focuses on creating a safer therapeutic approach for allergic people undergoing desensitization treatment. Ukko plans to develop a safer peanut allergy treatment by using their non-allergenic version of peanut protein.

    For gluten allergies, Ukko is working on a safe gluten protein that can be used for numerous products in both commercial and manufacturing markets. Interestingly, Ukko also plans to use its flour products to produce their own line of gluten-free bread that will be available commercially.

    Current investors in Ukko include lead investor Leaps by Bayer, the venture arm of the pharmaceutical giant, Continental Grain Company, PeakBridge Ventures, SkyViews Life Science and Fall Line Capital, Khosla Ventures, Innovation Endeavors, and TIME Ventures.

    Read more in Food Dive.


    User Feedback

    Recommended Comments

    Khastiana

    I have to wonder if these people realize other grains and grains proteins cause just as much damage as gluten itself, like quinoa.

    Link to comment
    Share on other sites
    trents
    1 hour ago, Khastiana said:

    I have to wonder if these people realize other grains and grains proteins cause just as much damage as gluten itself, like quinoa.

    Other than barley and rye, the two other gluten containing grains that celiacs and people with NCGS must avoid, I am not aware of other grains, with the possible exception of oats for some celiacs, that "cause as much damage as gluten itself. Certainly, quinoa has always been considered a safe alternative to wheat, barley and rye for celiacs. Can you be more specific please and can you provide some references to substantiate your claim?

    Link to comment
    Share on other sites


    Create an account or sign in to comment

    You need to be a member in order to leave a comment

    Create an account

    Sign up for a new account in our community. It's easy!

    Register a new account

    Sign in

    Already have an account? Sign in here.

    Sign In Now

  • Get Celiac.com Updates:
    Support Celiac.com:
    Donate
  • About Me

    Scott Adams

    Scott Adams was diagnosed with celiac disease in 1994, and, due to the nearly total lack of information available at that time, was forced to become an expert on the disease in order to recover. In 1995 he launched the site that later became Celiac.com to help as many people as possible with celiac disease get diagnosed so they can begin to live happy, healthy gluten-free lives.  He is co-author of the book Cereal Killers, and founder and publisher of the (formerly paper) newsletter Journal of Gluten Sensitivity. In 1998 he founded The Gluten-Free Mall which he sold in 2014. Celiac.com does not sell any products, and is 100% advertiser supported.


  • Celiac.com Sponsor (A17):
    Celiac.com Sponsor (A17):





    Celiac.com Sponsors (A17-M):




  • Related Articles

    Scott Adams
    What is the Treatment for Celiac Disease?
    Celiac.com 06/26/2020 - The only treatment for celiac disease is a gluten-free diet. 
    No Cure for Celiac Disease
    No prescription drug or home remedy can cure celiac disease. There is no operation or medical procedure that can cure celiac disease.
    Gluten-Free Diet Key to Celiac Wellness
    However, people with celiac disease can live happy, healthy, normal lives by eliminating wheat rye and/or barley, and following a dedicated gluten-free diet.
    Avoid Unsafe Non-Gluten-Free Foods
    This means avoiding all products derived from wheat, rye, barley, oats, and a few other lesser-known grains. These foods and ingredients are unsafe and not-gluten-free. Here's our Unsafe Gluten-Free Food List (Unsafe Ingredients).
    Eat Safe Gluten-Free Foods
    Eat only f...


    Jefferson Adams
    Investors Bet Big on Vaccine Therapy for Celiac Disease
    Celiac.com 12/22/2017 - Venture capital firms Arch Venture, and Vatera are betting big on biotech startup ImmusanT, the makers of potential celiac disease vaccine Nexvax2.
    Arch and Vatera have funded a $40 million B round that will support ImmusanT's development of their celiac treatment through Phase II testing. Full data are expected in mid-2019.
    As part of it's efforts, Arch Venture partner and former head of research at Celgene, Tom Daniel, will join the board at ImmusanT. Additionally, renowned immunologist and Arch managing director Steven Gillis will also join the board at ImmusanT.
    Nexvax2 is the first prong in ImmusanT's efforts to develop a treatment that creates immune system tolerance to thwart autoimmune diseases. If they are successful in tackling celiac disease...


    Jefferson Adams
    Peptide Immunotherapy for Type 1 Diabetes is Fast Becoming a Reality
    Celiac.com 10/29/2018 - Researchers Emma L. Smith with UCB Pharma Ltd., Slough, United Kingdom, and Mark Peakman from the Department of Immunobiology, King’s College London, London, United Kingdom recently set out to catalog clinical advances in peptide immunotherapy for Type 1 diabetes.
    Autoimmune and allergic diseases occur when a person’s body has an incorrect immune response to an antigen from the person’s own body, or to an innocuous antigen from outside the body. This triggers a pathogenic T-cell response which causes damage to certain tissues and organs. In Type 1 diabetes, this process results in the destruction of the insulin-secreting β cells, which leads to permanent need for recombinant insulin to make up for the loss. 
    The best way to restore immune homeostasi...


    Scott Adams
    The Appeal of Vaccine Treatments for Celiac Disease
    Celiac.com 12/21/2020 - Recent leaps in understanding the development of celiac disease have led efforts toward a new, non-dietary, vaccine therapy. 
    A lifelong gluten-free diet remains the only treatment for celiac disease, but research shows that even the most diligent gluten-free dieters are likely to be exposed to gluten on a regular basis. This is part of the appeal of safe, effective non-dietary treatments for celiac disease. And adjunctive and/or vaccine therapy is one of those approaches.
    New therapies might focus on immune regulation by IL-10, as in vitro models of treated celiac patients show that external IL-10 can overwhelm the gliadin driven IFN-γ response in intestinal biopsies. But, even though people with active celiac disease show high levels of anti-infl...


  • Recent Activity

    1. - trents replied to Art Maltman's topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      My 5 months of Struggle

    2. - Scott Adams replied to Dana Gilcrease's topic in Gluten-Free Foods, Products, Shopping & Medications
      4

      Gluten-Free Foods

    3. - Art Maltman posted a topic in Celiac Disease Pre-Diagnosis, Testing & Symptoms
      2

      My 5 months of Struggle


  • Celiac.com Sponsor (A19):



  • Member Statistics

    • Total Members
      126,485
    • Most Online (within 30 mins)
      7,748

    Gonza
    Newest Member
    Gonza
    Joined

  • Celiac.com Sponsor (A20):


  • Forum Statistics

    • Total Topics
      120.9k
    • Total Posts
      69.4k

  • Celiac.com Sponsor (A22):





  • Celiac.com Sponsor (A21):



  • Popular Now

    • JA917
      11
    • Dana Gilcrease
      4
    • marion wheaton
      6
    • Jula
    • GardeningForHealth
  • Popular Articles

    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
    • Scott Adams
  • Upcoming Events

×
×
  • Create New...